InvestorsHub Logo
Followers 155
Posts 2675
Boards Moderated 0
Alias Born 01/29/2004

Re: MayoMobile post# 369827

Tuesday, 08/09/2022 6:04:39 PM

Tuesday, August 09, 2022 6:04:39 PM

Post# of 469633
Thanks for this posting.

I found this Missling statement of particular interest:

...we have adequate manufacturing and supply in place for a rollout assuming approval and commercialization....


I believe this is further substantiation of the ease of blarcamesine synthesis; meaning that it can be and may already have been farmed out to a drug supply contractor. Daily 50mg doses won't be expensive to manufacture; works to the benefit of the company, its shareholders, and patients. All-win.

All of the other presented information is positive. Read the material with scrutiny. The Anavex story continues to develop so positively. Great things in the (near) future.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News